4.1 Summary of randomized controlled trials (RCTs) Prospective, multicentric, RCTs have demonstrated that NAC offers multiple clinical benefits in COPD management
however, some conflicting evidence exists in the literature
Glutathione biosynthesis in Escherichia coli K 12
Patients may lose an additional 5-10% of body weight during this phase, with rate of loss gradually decreasing
Research highlights the observed activity of GHK-Cu in protecting lungs from fibrosis following bleomycin therapy, suggesting its potential interest as a chemotherapy adjuvant research subject to investigate increased medication doses without exacerbating side effects
Nausea, vomiting, diarrhoea, and constipation affect a substantial proportion of patients starting liraglutide